Aptus Pharma Plans ₹51 Cr Fund Raise for Expansion

Aptus Pharma Limited's Board of Directors has approved a proposal to raise up to ₹51 crore for business expansion. The fundraising will be a combination of a preferential allotment of securities up to ₹35 crore, debt finance up to ₹10 crore, and internal accruals of ₹6 crore. The preferential allotment is subject to necessary approvals, including shareholder and regulatory clearances. The Board has delegated authority to the Managing Director to identify and negotiate with prospective investors for the preferential allotment, with final approvals to be sought in subsequent meetings.